Kris Kobach, the Attorney General of Kansas, announced that the state will receive $ 5.7 million from eight companies that manufactured Opioid Pills as part of a total of $ 770 million in national settlement.
The consensus of Kansas is based on how the influence of the opioid crisis and the court procedure in each state. The company includes:
- MyLan (currently part of Viatris): $ 284,447,916 I paid for 9 years.
- Hikma: $ 95,818,293 paid over 1 to 4 years.
- Yangbijang: $ 71,751,010 has been paid for 10 years.
- Apotex: $ 63,682,369 in a year.
- Indivior: $ 38,022,450 has been paid over four years.
- Sun: $ 30,992,087 has been paid over 1-4 years.
- ALVOGEN: $ 18,680,162 in a year.
- Zydus: $ 14,859,220 in a year.
Each company can no longer promote or market opioids, and cannot sell products with more than 40 mg oxicodon per pill, except for individuals that have not manufactured or sells Opioid products for 10 years. You also need to use monitoring and reporting systems for suspicious spells.
Payment can start in 2026, a total of 45 stocks have been agreed to agree, and were negotiated by lawyers in North Carolina, Colorado, Illinoi, Illinoi, New York, Origan, Tennessee, Utah and Virginia.
General Lawyer Lee announced the agreement on July 10 and allowed other states to sign the agreement for the next few days.
“We are responsible for human suffering caused by illegal marketing practices for many years,” said Kobach. “This dollar will help to save life because it is used to prevent and treat drug addiction throughout Kansas.”
The whole country has seen an increase in overdose due to opioids over the past 20 years. Kansas recorded 613 fatal drug addiction in 2023 Ministry of Health and Environment At least 63%of overdose deaths are related to opioids.
